Skip to main content
Công ty Cổ phần Dược phẩm Imexpharm logo

Công ty Cổ phần Dược phẩm Imexpharm — Investor Relations & Filings

Ticker · IMP ISIN · VN000000IMP0 HSX Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2020-07-31 Regulatory Filings
Country VN Viet Nam
Listing HSX IMP

About Công ty Cổ phần Dược phẩm Imexpharm

www.imexpharm.com

Imexpharm Corporation is a prominent pharmaceutical company with over 48 years of experience in the manufacturing, compounding, and distribution of high-quality pharmaceutical products. The company operates extensive production facilities, including three EU-GMP certified factory clusters and one WHO-GMP certified cluster, making it a leader in EU-GMP compliant manufacturing. Imexpharm is recognized as a top producer of antibiotics and offers a diverse product portfolio encompassing injectable and oral antibiotics, cardiovascular, ophthalmic, musculoskeletal, respiratory, and digestive system treatments, alongside vitamins, minerals, and health protection foods. With 28 product registrations for 11 products in Europe, Imexpharm is dedicated to delivering effective and safe healthcare solutions to the community.

Recent filings

Filing Released Lang Actions
IMP: Giấy chứng nhận đăng ký doanh nghiệp thay đổi lần thứ 28
Regulatory Filings Classification · 91% confidence The document is a disclosure to the State Securities Commission and Ho Chi Minh Stock Exchange of the company’s updated business registration certificate (28th amendment) filed within 24 hours, containing corporate registration details, legal representative data, charter capital, etc. It is not a financial report, earnings release, proxy, management change notice, or another specific category, but a routine regulatory filing. Therefore it falls under the generic Regulatory Filings (RNS) category.
2020-07-31 Vietnamese
IMP: Báo cáo tình hình quản trị công ty 6 tháng đầu năm 2020
Governance Information Classification · 90% confidence The document is a “Báo cáo tình hình quản trị công ty” (Report on the Company’s Corporate Governance) for the first half of 2020, addressed to the securities regulator and stock exchange. It details the governance structure, board and supervisory board activities, resolutions, and internal governance practices. This aligns with the Governance Information category (CGR).
2020-07-29 Vietnamese
IMP: Báo cáo về thay đổi sở hữu của cổ đông lớn Quỹ đầu tư cân bằng Tuệ Sáng VinaCapital
Major Shareholding Notification Classification · 90% confidence The document is a formal report titled “BÁO CÁO VỀ THAY ĐỔI SỞ HỮU CỦA CỔ ĐÔNG LỚN” addressed to the State Securities Commission and Ho Chi Minh Stock Exchange. It details the change in shareholding percentages of a major shareholder and related parties before and after a transaction, including exact share counts and thresholds. This matches the definition of a Major Shareholding Notification (MRQ) rather than a company share repurchase (POS) or other categories.
2020-07-24 Vietnamese
IMP: Báo cáo kết quả giao dịch cổ phiếu của người nội bộ Đỗ Thị Thanh Thúy
Director's Dealing Classification · 92% confidence The document is a standard insider transaction report (“Report on Results of Transaction in Shares/Fund Certificates of Internal Person…”) filed with the securities regulator and exchange. It details personal share transactions by an internal person of a public company. This clearly matches the “Director’s Dealing” category (insider trades).
2020-07-23 Vietnamese
IMP: Thông báo giao dịch cổ phiếu của người nội bộ Đỗ Thị Thanh Thúy
Director's Dealing Classification · 92% confidence The document is a Vietnamese regulatory notice (Appendix 10) disclosing an insider (a supervisory board member) transaction in company shares, specifying pre‐transaction holdings, sale quantity, and purpose. This matches the definition of a Director’s Dealing (insider share transactions by company executives/directors).
2020-07-20 Vietnamese
IMP: Thông báo thay đổi số lượng cổ phiếu có quyền biểu quyết đang lưu hành
Share Issue/Capital Change Classification · 93% confidence The document is an announcement by Imexpharm Corporation to the State Securities Commission and Ho Chi Minh Stock Exchange disclosing changes in its outstanding voting shares and charter capital. It details the previous, change, and after figures for total shares and outstanding voting shares due to issuance of shares for 2019 dividends and bonus shares. This matches the definition for Share Issue/Capital Change (SHA).
2020-07-20 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.